Follow-The-Filings

Security · featured owners

IMVT

Immunovant Inc. COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 1.1%
  • $229M
  • 1 add 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 1.1% (Nathan Fischel - Dafna Ca...) · not free-float ownership

  1. Nathan Fischel reduce 1.1%
  2. Farallon Capital Management add 1.0%

holders

sorted by % of portfolio · long equity only · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 1.1% Reduce −0.7% 149,524 $6M hist
Farallon Capital Management 2026 Q2 1.0% Add +275.5% 5,805,000 $224M hist

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue — — — —
Gross profit — — — —
Gross margin — — — —
Net income -$210.96M -$259.34M -$413.84M -$505.61M
Net margin — — — —

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $404.33M $665.77M $767.66M $948.82M
Total non-current assets * $1.5M $595,000 $8.56M $8.2M
Total assets $405.84M $666.36M $776.22M $957.01M
Total current liabilities $43.3M $48.61M $68.78M $104.42M
Total non-current liabilities * $47,000 $0.00 $0.00 $0.00
Total equity $362.49M $617.76M $707.45M $852.59M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations -$188.19M -$214.23M -$375.87M -$407.31M
Cash from investing -$197,000 -$360,000 -$759,000 -$8,000
Cash from financing $70.88M $472.43M $454.49M $595.76M
Net change in cash -$117.28M $258.83M $78.61M $188.14M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders